Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 295.15 USD | -0.58% |
|
-0.05% | -2.59% |
| Jul. 01 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| Jun. 03 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 7,905 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | -3.73% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 7,156 | 6,940 | 6,799 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | -9.12% | -3.02% | -2.04% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 35.5x | 34.7x | 34.9x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | 1.14x | 1.1x | - |
| PEG | - | - | - | -0x | -0x | -0.5x | 15.19x | -49.5x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.08x | 3x | 2.95x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 2.79x | 2.63x | 2.54x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 18x | 16.3x | 15.4x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 26.8x | 23.3x | 21.1x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 22.9x | 22.1x | 20.9x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 4.36% | 4.52% | 4.79% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,567 | 2,635 | 2,676 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 398.6 | 426.3 | 442.3 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 266.8 | 298 | 322 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 295.15 | 295.15 | 295.15 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,762 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.68x | 2.8x | 18.05x | -.--% | 7.94B | |
| 23.6x | 3.54x | 13.29x | 2.67% | 166B | |
| 18.86x | 3.29x | 11.59x | 3.56% | 106B | |
| 16.3x | 0.18x | 11.67x | 0.8% | 57.69B | |
| 32.78x | 7.96x | 20.82x | 1.23% | 53.78B | |
| 39.39x | 3.1x | 10.64x | 2.44% | 43.56B | |
| 41.35x | 1.48x | 13.02x | 0.19% | 36.52B | |
| 29.11x | 5.18x | 16.53x | -.--% | 27.49B | |
| 43.44x | 7.53x | 27.19x | 0.24% | 25.84B | |
| 24x | 3.51x | 12.61x | 1.21% | 21.27B | |
| Average | 30.45x | 3.86x | 15.54x | 1.23% | 54.67B | |
| Weighted average by Cap. | 26.66x | 3.66x | 14.16x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
